AT298667B - Verfahren zur Herstellung von pharmazeutischen Zebereitungen - Google Patents
Verfahren zur Herstellung von pharmazeutischen ZebereitungenInfo
- Publication number
- AT298667B AT298667B AT535970A AT535970A AT298667B AT 298667 B AT298667 B AT 298667B AT 535970 A AT535970 A AT 535970A AT 535970 A AT535970 A AT 535970A AT 298667 B AT298667 B AT 298667B
- Authority
- AT
- Austria
- Prior art keywords
- production
- pharmaceutical preparations
- preparations
- pharmaceutical
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2778768A GB1279412A (en) | 1968-06-11 | 1968-06-11 | Gastric hydrochloric acid secretion inhibitor, process for the manufacture of such compounds, pharmaceutical composition and a method for the inhibition of gastric hydrochloric acid secretion |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT298667B true AT298667B (de) | 1972-05-25 |
Family
ID=10265313
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT535670A AT293428B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
| AT535970A AT298667B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von pharmazeutischen Zebereitungen |
| AT552669A AT292012B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
| AT535870A AT293430B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
| AT535770A AT293429B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
| AT535570A AT294849B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT535670A AT293428B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT552669A AT292012B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
| AT535870A AT293430B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
| AT535770A AT293429B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
| AT535570A AT294849B (de) | 1968-06-11 | 1969-06-11 | Verfahren zur Herstellung von neuen Estern von N-substituierten Carbaminsäuren |
Country Status (11)
| Country | Link |
|---|---|
| AT (6) | AT293428B (de) |
| BE (1) | BE734033A (de) |
| BR (1) | BR6909672D0 (de) |
| CH (2) | CH539021A (de) |
| DE (1) | DE1929416A1 (de) |
| DK (1) | DK126035B (de) |
| ES (3) | ES368207A1 (de) |
| FR (2) | FR2010650B1 (de) |
| GB (1) | GB1279412A (de) |
| IE (1) | IE33149B1 (de) |
| NL (1) | NL6908843A (de) |
-
1968
- 1968-06-11 GB GB2778768A patent/GB1279412A/en not_active Expired
-
1969
- 1969-06-04 BE BE734033D patent/BE734033A/xx unknown
- 1969-06-09 IE IE78169A patent/IE33149B1/xx unknown
- 1969-06-09 FR FR6919022A patent/FR2010650B1/fr not_active Expired
- 1969-06-10 CH CH1500471A patent/CH539021A/de not_active IP Right Cessation
- 1969-06-10 DK DK312369A patent/DK126035B/da unknown
- 1969-06-10 ES ES368207A patent/ES368207A1/es not_active Expired
- 1969-06-10 DE DE19691929416 patent/DE1929416A1/de active Pending
- 1969-06-10 CH CH880769A patent/CH525193A/de not_active IP Right Cessation
- 1969-06-10 NL NL6908843A patent/NL6908843A/xx unknown
- 1969-06-11 AT AT535670A patent/AT293428B/de not_active IP Right Cessation
- 1969-06-11 AT AT535970A patent/AT298667B/de not_active IP Right Cessation
- 1969-06-11 BR BR20967269A patent/BR6909672D0/pt unknown
- 1969-06-11 AT AT552669A patent/AT292012B/de not_active IP Right Cessation
- 1969-06-11 AT AT535870A patent/AT293430B/de not_active IP Right Cessation
- 1969-06-11 AT AT535770A patent/AT293429B/de not_active IP Right Cessation
- 1969-06-11 AT AT535570A patent/AT294849B/de not_active IP Right Cessation
-
1971
- 1971-02-27 ES ES388703A patent/ES388703A1/es not_active Expired
- 1971-02-27 ES ES71388702A patent/ES388702A1/es not_active Expired
-
1972
- 1972-06-14 FR FR7221354A patent/FR2140246A1/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DK126035B (da) | 1973-06-04 |
| DE1929416A1 (de) | 1970-07-16 |
| IE33149L (en) | 1969-12-11 |
| IE33149B1 (en) | 1974-04-03 |
| GB1279412A (en) | 1972-06-28 |
| ES388702A1 (es) | 1973-05-16 |
| BE734033A (de) | 1969-11-17 |
| ES388703A1 (es) | 1974-02-16 |
| BR6909672D0 (pt) | 1973-03-13 |
| AT293428B (de) | 1971-10-11 |
| AT293430B (de) | 1971-10-11 |
| FR2010650A1 (de) | 1970-02-20 |
| AT292012B (de) | 1971-08-10 |
| NL6908843A (de) | 1969-12-15 |
| AT293429B (de) | 1971-10-11 |
| FR2140246A1 (de) | 1973-01-12 |
| CH525193A (de) | 1972-07-15 |
| FR2010650B1 (de) | 1975-01-10 |
| CH539021A (de) | 1973-08-31 |
| AT294849B (de) | 1971-12-10 |
| ES368207A1 (es) | 1972-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT287205B (de) | Verfahren zur Herstellung von Arzneimittelzubereitungen | |
| CH532571A (de) | Verfahren zur Herstellung von 3-Amidopyrrolidinen | |
| CH513786A (de) | Verfahren zur Herstellung von Styrylnaphthalin-Derivaten | |
| AT285811B (de) | Verfahren zur Herstellung haltbarer Vitaminzubereitungen | |
| AT306930B (de) | Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen | |
| AT289084B (de) | Verfahren zur Herstellung von Trimethyl-p-benzochinon | |
| CH529145A (de) | Verfahren zur Herstellung von 1-Aminoalkylbenzodiazepinderivaten | |
| CH500992A (de) | Verfahren zur Herstellung von pharmazeutischen Verbindungen | |
| AT282024B (de) | Verfahren zur Herstellung von Pigmentzubereitungen | |
| AT305200B (de) | Verfahren zur Herstellung von Zubereitungen von Polyadditionsprodukten | |
| AT306228B (de) | Verfahren zur Herstellung pharmazeutischer Zubereitungen | |
| CH532581A (de) | Verfahren zur Herstellung von 14-Hydroxynormorphinonderivaten | |
| CH486444A (de) | Verfahren zur Herstellung von 7-Cyan-cumarinen | |
| AT318920B (de) | Verfahren zur Herstellung stabiler Zubereitungen | |
| CH529132A (de) | Verfahren zur Herstellung von 3-Indolylacetamidderivaten | |
| AT286252B (de) | Verfahren zur Herstellung von 3-Aminopropanolen | |
| AT292205B (de) | Verfahren zur Herstellung von 1-Peracylglykosyl-5-azacytosinen | |
| CH519458A (de) | Verfahren zur Herstellung von Isoprenoidchinonderivaten | |
| CH518956A (de) | Verfahren zur Herstellung von Isochinuclidin-Derivaten | |
| CH529835A (de) | Verfahren zur Herstellung von Eiweiss | |
| CH513863A (de) | Verfahren zur Herstellung von Benzomorphanderivaten | |
| AT296251B (de) | Verfahren zur Herstellung von Methylcyclohexenen | |
| CH534131A (de) | Verfahren zur Herstellung von Peptidderivaten | |
| AT288596B (de) | Verfahren zur Herstellung pharmazeutischer Präparate | |
| AT297216B (de) | Verfahren zur Herstellung von therapeutischen Zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |